Renal Cell Carcinoma Highlights From ASCO GU 2024 Renal Cell Carcinoma Highlights From ASCO GU 2024

Key data in renal cell carcinoma from ASCO GU 2024 includes pembrolizumab in early higher-risk RCC, belzutifan in advanced disease, and developments in quality-of-life tools.Medscape

Source: Medscape Today Headlines - February 16, 2024 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news